Time to patient presentation was the largest component of time to diagnosis of inflammatory bowel disease, according to research published in Alimentary Pharmacology & Therapeutics.James R. Goodhand, of Exeter IBD and Pharmacogenetics Research Group in the United Kingdom, and colleagues wrote that a timely diagnosis in IBD is critical for management of the disease.“Contemporary studies of the time to diagnosis of IBD from the UK, where healthcare is free at the point-of-access and general practitioners act as gatekeepers to secondary care services, are lacking,” they wrote. “MostRead More